GRIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.156550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.497600E-01
Normal-vs-Stage2
1.257390E-01
Normal-vs-Stage3
1.852970E-01
Normal-vs-Stage4
3.516000E-01
Stage1-vs-Stage2
8.408000E-01
Stage1-vs-Stage3
6.093700E-02
Stage1-vs-Stage4
8.588000E-01
Stage2-vs-Stage3
8.015200E-04
Stage2-vs-Stage4
9.785200E-01
Stage3-vs-Stage4
2.879400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.206410E-01
Normal-vs-AfricanAmerican
2.735200E-01
Normal-vs-Asian
2.277600E-01
Caucasian-vs-AfricanAmerican
7.843400E-01
Caucasian-vs-Asian
6.232600E-01
AfricanAmerican-vs-Asian
9.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.851020E-01
Normal-vs-Female
6.379700E-02
Male-vs-Female
3.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.005800E-01
Normal-vs-Age(41-60Yrs)
3.277400E-01
Normal-vs-Age(61-80Yrs)
7.431600E-02
Normal-vs-Age(81-100Yrs)
3.843800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.075800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.629400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.010800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.229600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.043750E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.062000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.693900E-02
Normal-vs-Daily Drinker
2.360800E-01
Normal-vs-Weekly Drinker
7.612300E-02
Normal-vs-Occasional Drinker
5.675400E-01
Normal-vs-Social Drinker
2.073800E-01
Non Drinker-vs-Daily Drinker
2.157600E-01
Non Drinker-vs-Weekly Drinker
9.585000E-01
Non Drinker-vs-Occasional Drinker
2.425800E-01
Non Drinker-vs-Social Drinker
1.443190E-01
Daily Drinker-vs-Weekly Drinker
2.848400E-01
Daily Drinker-vs-Occasional Drinker
9.110100E-02
Daily Drinker-vs-Social Drinker
1.236460E-02
Weekly Drinker-vs-Occasional Drinker
2.864400E-01
Weekly Drinker-vs-Social Drinker
2.624800E-01
Occasional Drinker-vs-Social Drinker
7.444000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.776100E-02
Normal-vs-Grade 2
1.048020E-01
Normal-vs-Grade 3
8.168300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.219800E-01
Grade 1-vs-Grade 3
7.813000E-01
Grade 1-vs-Grade 4
9.776100E-02
Grade 2-vs-Grade 3
9.432200E-01
Grade 2-vs-Grade 4
1.048020E-01
Grade 3-vs-Grade 4
8.168300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.787700E-02
Normal-vs-NonDiabetic
1.237790E-01
Diabetic-vs-NonDiabetic
3.582200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.888200E-01
Normal-vs-NoPancreatitis
1.108390E-01
Pancreatitis-vs-NoPancreatitis
4.721200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.498200E-02
Normal-vs-N1
1.413800E-01
N0-vs-N1
5.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.196800E-01
Normal-vs-TP53-NonMutant
3.570800E-01
TP53-Mutant-vs-TP53-NonMutant
5.472400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
